School of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Maricopa Integrated Health System, Phoenix, AZ 85008.
Mol Cell Proteomics. 2019 Oct;18(10):2121-2137. doi: 10.1074/mcp.TIR119.001659. Epub 2019 Jul 19.
Exposure of blood plasma/serum (P/S) to thawed conditions (> -30 °C) can produce biomolecular changes that skew measurements of biomarkers within archived patient samples, potentially rendering them unfit for molecular analysis. Because freeze-thaw histories are often poorly documented, objective methods for assessing molecular fitness before analysis are needed. We report a 10-μl, dilute-and-shoot, intact-protein mass spectrometric assay of albumin proteoforms called "ΔS-Cys-Albumin" that quantifies cumulative exposure of archived P/S samples to thawed conditions. The relative abundance of S-cysteinylated (oxidized) albumin in P/S increases inexorably but to a maximum value under 100% when samples are exposed to temperatures > -30 °C. The difference in the relative abundance of S-cysteinylated albumin (S-Cys-Alb) before and after an intentional incubation period that drives this proteoform to its maximum level is denoted as ΔS-Cys-Albumin. ΔS-Cys-Albumin in fully expired samples is zero. The range (mean ± 95% CI) observed for ΔS-Cys-Albumin in fresh cardiac patient P/S ( = 97) was, for plasma 12-29% (20.9 ± 0.75%) and for serum 10-24% (15.5 ± 0.64%). The multireaction rate law that governs S-Cys-Alb formation in P/S was determined and shown to predict the rate of formation of S-Cys-Alb in plasma and serum samples-a step that enables back-calculation of the time at which unknown P/S specimens have been exposed to room temperature. A blind challenge demonstrated that ΔS-Cys-Albumin can detect exposure of groups ( = 6 each) of P/S samples to 23 °C for 2 h, 4 °C for 16 h, or -20 °C for 24 h-and exposure of individual specimens for modestly increased times. An unplanned case study of nominally pristine serum samples collected under NIH-sponsorship demonstrated that empirical evidence is required to ensure accurate knowledge of archived P/S biospecimen storage history.
将血血浆/血清(P/S)暴露于解冻条件(>-30°C)下会产生生物分子变化,从而改变存档患者样本中生物标志物的测量结果,使其可能不适合分子分析。由于冷冻-解冻历史通常记录不佳,因此需要在分析之前使用客观方法来评估分子适用性。我们报告了一种 10μl 的稀释-射击法,用于完整蛋白质质谱分析称为“ΔS-Cys-Albumin”的白蛋白蛋白形式,该方法可定量量化存档 P/S 样品对解冻条件的累积暴露。当样品暴露于温度>-30°C 时,S-半胱氨酸化(氧化)白蛋白在 P/S 中的相对丰度会不断增加,但最大值不超过 100%。在故意孵育期间驱动该蛋白形式达到最大水平后,S-半胱氨酸化白蛋白(S-Cys-Alb)的相对丰度的差异表示为ΔS-Cys-Albumin。完全过期样品中的ΔS-Cys-Albumin 为零。在新鲜的心脏病患者 P/S 中观察到的ΔS-Cys-Albumin 范围(平均值±95%置信区间)为,血浆为 12-29%(20.9±0.75%),血清为 10-24%(15.5±0.64%)。确定了控制 P/S 中 S-Cys-Alb 形成的多反应速率定律,并表明该定律可以预测血浆和血清样品中 S-Cys-Alb 的形成速率-这是可以回溯未知 P/S 标本暴露于室温的时间的步骤。一项盲法挑战表明,ΔS-Cys-Albumin 可以检测到 P/S 样本(每组 6 个)在 23°C 下暴露 2 小时,在 4°C 下暴露 16 小时或在-20°C 下暴露 24 小时,以及单个标本适度增加的暴露时间。NIH 赞助下收集的名义上原始血清样本的计划外案例研究表明,需要经验证据来确保准确了解存档 P/S 生物样本存储历史。